Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1989; 13:421-425
© 1989 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waters, D.
Right arrow Articles by Brien, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waters, D.
Right arrow Articles by Brien, M

Limited usefulness of intermittent nitroglycerin patches in stable angina

DD Waters, M Juneau, D Gossard, G Choquette, and M Brien

Department of Medicine, Montreal Heart Institute, Quebec, Canada.

The efficacy of continuous and intermittent nitroglycerin patches (10 mg/day) was compared in a randomized, placebo-controlled trial in 36 patients with stable angina and reproducible, exercise-induced ST depression. Intermittent treatment was administered either 18 or 14 h/day with an intermission of 6 h or 10 h, respectively. Exercise tests were performed during the last 2 h of patch application. Compared with placebo, neither continuous nitroglycerin nor the two intermittent regimens prolonged total treadmill time or time to 1 mm ST depression. No treatment eliminated exercise-induced ST depression in greater than 1 of the 36 patients. Time to angina was prolonged (by 40 +/- 66 s) only during the "10 h off" treatment (p = 0.001); time to angina increased by greater than or equal to 20% in 13 patients. Responders to treatment could be predicted by a short history of angina (p less than 0.05) and a time to angina less than or equal to 250 s during the placebo test. For each treatment, greater than or equal to 25 of the patients reported headache; 4 additional patients dropped out because of severe headache and 2 others because of a coronary event in a washout period. Thus, in most patients with stable angina, side effects outweight any benefit demonstrable with this therapy.


This article has been cited by other articles:


Home page
ChestHome page
J. George, I. Kitzis, D. Zandorf, M. Golovner, I. Shapira, S. Laniado, and A. Roth
Safety of Nitrate Withdrawal in Angina-Free and Hemodynamically Stable Patients With Coronary Artery Disease
Chest, November 1, 2003; 124(5): 1652 - 1657.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Hebert and J. Y. T. Lam
Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2311 - 2316.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. D. Parker and J. O. Parker
Nitrate Therapy for Stable Angina Pectoris
N. Engl. J. Med., February 19, 1998; 338(8): 520 - 531.
[Full Text] [PDF]


Home page
BMJHome page
North of England Stable Angina Guideline Developme
North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management of stable angina
BMJ, March 30, 1996; 312(7034): 827 - 832.
[Full Text]


Home page
CirculationHome page
J. D. Parker, A. B. Parker, B. Farrell, and J. O. Parker
Intermittent Transdermal Nitroglycerin Therapy : Decreased Anginal Threshold During the Nitrate-Free Interval
Circulation, February 15, 1995; 91(4): 973 - 978.
[Abstract] [Full Text]


Home page
Arch Fam MedHome page
U. Thadani
Nitrate Therapy and the Development of Tolerance
Arch Fam Med, August 1, 1993; 2(8): 880 - 885.
[Abstract] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement